Mackenzie Financial Corp Biogen Inc. Transaction History

Mackenzie Financial Corp

$63.2 Billion
Q2 2024

A detailed history of Mackenzie Financial Corp transactions in Biogen Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 25,664 shares of BIIB stock, worth $4.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,664

Previous 47,222 45.65%

Holding current value

$4.46 Million

Previous $10.2 Million 41.57%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $4.11 Million - $5.1 Million	-21,558 Reduced 45.65%	25,664 $5.95 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $2.84 Million - $3.59 Million	-13,404 Reduced 22.11%	47,222 $10.2 Million
Q4 2023 Jan 30, 2024	BUY	$222.59 - $267.94 $3.07 Million - $3.7 Million	13,796 Added 29.46%	60,626 $15.7 Million
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $1.07 Million - $1.2 Million	4,209 Added 9.88%	46,830 $12 Million
Q2 2023 Aug 03, 2023	SELL	$275.25 - $318.06 $816,942 - $944,002	-2,968 Reduced 6.51%	42,621 $12.1 Million
Q1 2023 Apr 24, 2023	SELL	$256.56 - $292.34 $121,609 - $138,569	-474 Reduced 1.03%	45,589 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $1.89 Million - $2.3 Million	-7,491 Reduced 13.99%	46,063 $12.8 Million
Q3 2022 Oct 07, 2022	SELL	$194.69 - $268.46 $2.24 Million - $3.08 Million	-11,486 Reduced 17.66%	53,554 $14.3 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $3.81 Million - $4.54 Million	20,338 Added 45.5%	65,040 $13.3 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $38,172 - $48,095	197 Added 0.44%	44,702 $9.41 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.05 Million - $1.35 Million	4,691 Added 11.78%	44,505 $10.7 Million
Q3 2021 Nov 08, 2021	SELL	$282.99 - $369.05 $1.88 Million - $2.45 Million	-6,627 Reduced 14.27%	39,814 $11.3 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $292,152 - $467,792	-1,128 Reduced 2.37%	46,441 $16.1 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $7.44 Million - $8.72 Million	-30,622 Reduced 39.16%	47,569 $13.3 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $588,051 - $885,163	2,489 Added 3.29%	78,191 $19.1 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1.25 Million - $1.44 Million	-4,716 Reduced 5.86%	75,702 $21.5 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $15.7 Million - $20.8 Million	60,611 Added 306.01%	80,418 $21.5 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $1.7 Million - $2.15 Million	-6,311 Reduced 24.16%	19,807 $6.27 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $951,539 - $1.31 Million	-4,324 Reduced 14.2%	26,118 $7.75 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $136,987 - $153,644	630 Added 2.11%	30,442 $7.09 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1.74 Million - $1.92 Million	-7,928 Reduced 21.01%	29,812 $6.97 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $78.3 Million - $123 Million	-361,413 Reduced 90.54%	37,740 $8.92 Million
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $19.3 Million - $24.4 Million	69,178 Added 20.96%	399,153 $120 Million
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $86.6 Million - $113 Million	295,060 Added 845.08%	329,975 $117 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $214,256 - $255,349	832 Added 2.44%	34,915 $10.1 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $7.92 Million - $11.2 Million	-30,461 Reduced 47.19%	34,083 $9.33 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $19.9 Million - $22.2 Million	64,544	64,544 $20.6 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Biogen Inc. Transaction History